US$ 21.74
dyer semaglutide Compounded Semaglutide in Winter Garden |
Description
Our cartridge platform addresses the rapidly growing demand for GLP-1s, and self-administered injectable therapies under full EU Annex 1 expectations

For medical concerns, consult the doctor

Five clinical trials in type 2-diabetic subjects (SURPASS 15) have shown that tirzepatide at 515 mg per week reduces both HbA1c (1.24 to 2.58%) and body weight (5.411.7 kg) by amounts unprecedented for a single agent

This product is sold strictly for in-vitro research and laboratory use only

Fast Acting: The ingredients are specially "micronized" (broken down into tiny particles) so your body can absorb them and start working immediately
